24683-26-9,
113913-36-3,
Ethyl 4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxylate 1,1-dioxide,
Ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide,
UNII-EAD64Z1YS1,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester 1,1-dioxide,
EINECS 246-403-7,
EAD64Z1YS1,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester-1,1-dioxide,
CHEMBL598364,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-1,1-dioxide-3-carboxylic acid ethyl ester,
Ethyl 4-hydroxy-2-methyl-1,1-dioxo-2H-1,2-benzothiazine-3-carboxylate,
2H-1,2-Benzothiazine-3-carboxylic acid, 4-hydroxy-2-methyl-, ethyl ester, 1,1-dioxide,
4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid ethylester 1,1-dioxide,
W-107287,
4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic Acid Ethyl Ester 1,1-Dioxide,
2H-1,2-Benzothiazine-3-carboxylicacid, 3,4-dihydro-4-hydroxy-2-methyl-, ethyl ester, 1,1-dioxide,
Meloxicam Related Compound A,
Piroxicam Impurity K,
AC1NTQV3,
AC1NUN8H,
ACMC-20a66v,
EC 246-403-7,
AC1L3KA6,
SCHEMBL2345581,
Jsp001058,
CTK4A8514,
DTXSID30179415,
QWTNANUGXZEPFQ-UHFFFAOYSA-N,
ANW-58949,
BDBM50309938,
CE-243,
MFCD00190168,
STL384274,
AKOS015889481,
Ethyl 2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylater 1,1-dioxide,
ZINC100014894,
KS-5263,
MCULE-3645036865,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3 -carboxylic acid ethyl ester 1,1-dioxide,
ACM24683269,
NCGC00253615-01,
AC-19607,
AJ-54889,
AJ-54890,
AK-55972,
AN-33384,
CC-11386,
LS-40552,
SC-46208,
DB-041190,
TC-147694,
TL8000407,
FT-0638446,
FT-0642776,
M-1363,
C-17827,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxyl,
3-[ethoxy(hydroxy)methylidene]-2-methyl-1,1-dioxo-1,
I01-19877,
I14-14569,
I14-41758,
(3E)-3-[ethoxy(hydroxy)methylidene]-2-methyl-1,1-dioxo-1,
3-carbethoxy-4-hydroxy-2-methyl-2H-1,2-benzothiazine 1,1-dioxide,
Meloxicam impurity A, European Pharmacopoeia (EP) Reference Standard,
ethyl 4-hydroxy-2-methyl-1,1-dioxo-1?^{6},2-benzothiazine-3-carboxylate,
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide,
(3Z)-3-[ethoxy(hydroxy)methylene]-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazin-4-one,
(4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid ethyl)1,1-dioxide,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-1,1-dioxide-3carboxylic acid ethyl ester,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylic acid ethyl ester1,1-dioxide,
2-Methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxylicacidethylester1,1-dioxide,
2H-1,2-Benzothiazine-3-carboxylic acid, 4-hydroxy-2-methyl-, ethylester, 1,1-dioxide,
Ethyl 4-hydroxy-2-methyl-1,1-dioxo-2H-1,2-benzothiazine-3-carboxylate, 97%,
Meloxicam Related Compound A, United States Pharmacopeia (USP) Reference Standard,
4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid ethyl ester,
Ethyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-Dioxide(Piroxicam Impurity K),
C12H13NO5S,
CID90580,
C12-H13-N-O5-S,
CID5386622,
CID5484087,
4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxyl,
(3Z)-3-[ethoxy(hydroxy)methylidene]-2-methyl-1,1-dioxo-1,
Ethyl 2-methyl-4-hydroxy-2H-1,2-benzothiazole-3-carboxylater 1,1-dioxide,
4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylicacidethylester-1,1-dioxide,